Free Trial

MBX Biosciences (MBX) Insider Trading & Ownership

MBX Biosciences logo
$20.36 +0.09 (+0.44%)
(As of 12/20/2024 05:16 PM ET)

MBX Biosciences (NYSE:MBX) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$18 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get MBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MBX Insider Buying and Selling by Quarter

MBX Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2024Edward T MathersDirectorBuy500,000$16.00$8,000,000.00  
9/16/2024Life Sciences X L.P. FrazierMajor ShareholderBuy625,000$16.00$10,000,000.00  
(Data available from 1/1/2013 forward)

MBX Insider Trading Activity - Frequently Asked Questions

The list of insiders at MBX Biosciences includes Edward T Mathers, and Life Sciences X L.P. Frazier. Learn more on insiders at MBX.

The following insiders have purchased MBX shares in the last 24 months: Edward T Mathers ($8,000,000.00), and Life Sciences X L.P. Frazier ($10,000,000.00).

Insiders have purchased a total of 1,125,000 MBX shares in the last 24 months for a total of $18,000,000.00 bought.

MBX Biosciences Key Executives

  • Mr. Peter Kent Hawryluk (Age 55)
    CEO, President & Director
    Compensation: $571.2k
  • Dr. Steven J. Prestrelski M.B.A. (Age 60)
    MBA, Ph.D., Chief Scientific Officer
  • Mr. Matt Gambino
    Vice President of Marketing
  • Ms. Michelle Graham (Age 57)
    Chief Human Resources Officer
  • Dr. Salomon Azoulay (Age 67)
    Chief Medical Officer


This page (NYSE:MBX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners